Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00067405 · ClinicalTrials.gov registry record · Phase 1
Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia
A Phase 1 study of Fibromyalgia, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- Completed
- Registry status
- Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT00067405: Completed Phase 1 study of Fibromyalgia, sponsored by National Center for Complementary and Integrative Health (NCCIH).
NCT00067405 is a Phase 1 study of Fibromyalgia that has completed, run by National Center for Complementary and Integrative Health (NCCIH). The registered enrollment target is 40 participants, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (78% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00067405, a Phase 1 study of Fibromyalgia, has completed, sponsored by National Center for Complementary and Integrative Health (NCCIH).
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is effective in the treatment of fibromyalgia, as assessed by validated functional and pain measures.
Conditions Studied
Interventions
- DRUG Intravenous micronutrient therapy
Study Locations (1)
Connecticut
- Yale-Griffin Prevention Research Center - Derby
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2004-06 |
| Est. Completion | 2007-07 |
| Phase | Phase 1 |
What the finished NCT00067405 record still lists
NCT00067405 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 179-participant average among 76 other Fibromyalgia trials with a reported enrollment target (78% lower).
The record links to 1 condition, with Fibromyalgia appearing as the primary indexed condition, and to 1 intervention - of which Intravenous micronutrient therapy is the first listed.
NCT00067405 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT00067405 about?
NCT00067405 is a clinical study titled "Intravenous Micronutrient Therapy (IVMT) for Fibromyalgia". The purpose of this study is to determine if intravenous micronutrient therapy (IVMT) is effective in the treatment of fibromyalgia, as assessed by validated functional and pain measures.
What is the current status of trial NCT00067405?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 40 participants. The study started on 2004-06. Estimated completion is 2007-07.
What conditions does trial NCT00067405 study?
This clinical trial studies the following conditions: Fibromyalgia.
What interventions are being tested in trial NCT00067405?
The interventions under investigation include: Intravenous micronutrient therapy (DRUG).
Who is sponsoring clinical trial NCT00067405?
This trial is sponsored by National Center for Complementary and Integrative Health (NCCIH), which has 203 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00067405 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Fibromyalgia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00067405's enrollment target sits among peer trials
40 54th of 76 higher than 21 of 76 other Fibromyalgia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Fibromyalgia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Assessment of Neuroinflammation in Central Inflammatory Disorders Using [F-18]DPA-714.
RECRUITING · Phase 1
-
Pain Management Techniques for Fibromyalgia
COMPLETED · Phase 1
-
TD-9855 Mass Balance Study
COMPLETED · Phase 1
-
Auricular Neuromodulation in Veterans With Fibromyalgia
RECRUITING · NA
-
Nitrous Oxide as Treatment for Fibromyalgia
RECRUITING · Phase 2
-
The Benefits of Natural Medicine, Vitamin IV Therapy and Supplements: Maintaining Good Health Through Nature
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia